Using small molecule reagents to selectively modify epitopes based on their conformation

Prion

Volumn 6, Issue 2, 2012, Pages 163-173

  Silva, Christopher J ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

263K; Antibody; Chemical modification; Conformation; Epitope; Mass spectrometry; Me7; Prion

Indexed keywords

ACETIC ACID; AMINO ACID; BRAIN EXTRACT; BUTYRIC ACID DERIVATIVE; DETERGENT; EPITOPE; N HYDROXYSUCCINIMIDE; PRION PROTEIN; PROTEINASE K; REAGENT;

ANIMAL TISSUE; CHEMICAL REACTION; CONFERENCE PAPER; CONFORMATION; CONTROLLED STUDY; HAMSTER; MOUSE; NONHUMAN; SURFACE PROPERTY; SYNTHESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CRICETINAE; EPITOPES; ESTERS; MESOCRICETUS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PRPSC PROTEINS; QUATERNARY AMMONIUM COMPOUNDS; SUCCINIMIDES;

CRICETINAE; MUS;

EID: 84861745028     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.18795     Document Type: Conference Paper

References (42)

1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363.
2. Stahl N, Baldwin M, Teplow DB, Hood LE, Beavis R, Chait B, et al. Cataloging post-translational modifications of the scrapie prion protein by mass spectrometry. In: Prusiner SB, Collinge J, Powell J, Anderton B, Eds. Prion diseases of humans and animals. New York: Ellis Horwood 1992; 361-79.
3. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157-65; PMID:9771749; http://dx.doi.org/10.1038/2654.
4. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991; 30:7672-80; PMID:1678278; http://dx.doi.org/10.1021/bi00245a003.
5. Onisko BC, Silva CJ, Requena JR. Methods to differentiate protein conformers Application number 20060110785. 2006.
6. Carter JM, Dynin I, Erickson ML, Onisko BC, Requena JR, Silva CJP. 1.8 Conformation-dependent covalent modification of PrP. Prion2009 September 23-25, 2009 Porto Carras, Chalkidiki Greece Book of Abstracts 2009; 54.
7. Lehto MT, Peery HE, Cashman NR. Current and future molecular diagnostics for prion diseases. Expert Rev Mol Diagn 2006; 6:597-611; PMID:16824033; http://dx.doi.org/10.1586/14737159.6.4.597.
8. Williamson RA, Peretz D, Pinilla C, Ball H, Bastidas RB, Rozenshteyn R, et al. Mapping the prion protein using recombinant antibodies. J Virol 1998; 72:9413-8; PMID:9765500.
9. Miller BT, Collins TJ, Rogers ME, Kurosky A. Peptide biotinylation with amine-reactive esters: differential side chain reactivity. Peptides 1997; 18:1585-95; PMID:9437720; http://dx.doi.org/10.1016/S0196-9781(97)00225-8.
10. Anjaneyulu PS, Staros JV. Reactions of N-hydroxysulfosuccinimide active esters. Int J Pept Protein Res 1987; 30:117-24; PMID:3667072; http://dx.doi.org/10.1111/j.1399-3011.1987.tb03319.x.
11. Onisko B, Fernández EG, Freire ML, Schwarz A, Baier M, Camiña F, et al. Probing PrPSc structure using chemical cross-linking and mass spectrometry: evidence of the proximity of Gly90 amino termini in the PrP 27-30 aggregate. Biochemistry 2005; 44:10100-9; PMID:16042387; http://dx.doi.org/10.1021/bi0501582.
12. Pimenova T, Nazabal A, Roschitzki B, Seebacher J, Rinner O, Zenobi R. Epitope mapping on bovine prion protein using chemical cross-linking and mass spectrometry. J Mass Spectrom 2008; 43:185-95; PMID:17924399; http://dx.doi.org/10.1002/jms.1280.
13. Kouassi GK, Irudayaraj J. A nanoparticle-based immobilization assay for prion-kinetics study. J Nanobiotechnology 2006; 4:8; PMID:16916458; http://dx.doi.org/10.1186/1477-3155-4-8.
14. Dumpitak C. Untersuchungen zu Struktur und Funktion von Polysacchariden und alterungsassoziierten Proteinmodifikationen bei Prionen. Dissertation. Düsseldorf: Heinrich-Heine-Universität 2003.
15. Prusiner SB. Prion Biology and Diseases. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press 2004.
16. Bibby DF, Gill AC, Kirby L, Farquhar CF, Bruce ME, Garson JA. Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins. J Virol Methods 2008; 151:107-15; PMID:18433888; http://dx.doi.org/10.1016/j.jviromet.2008.03.013.
17. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987; 61:3688-93; PMID:2446004.
18. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128-32; PMID:19242475; http://dx.doi.org/10.1038/nature07761.
19. Maddison BC, Whitelam GC, Gough KC. Cellular prion protein in ovine milk. Biochem Biophys Res Commun 2007; 353:195-9; PMID:17174270; http://dx.doi.org/ 10.1016/j.bbrc.2006.12.006.
20. Novitskaya V, Makarava N, Bellon A, Bocharova OV, Bronstein IB, Williamson RA, et al. Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J Biol Chem 2006; 281:15536-45; PMID:16569635; http://dx.doi.org/10.1074/jbc.M601349200.
21. Spinner DS, Kascsak RB, Lafauci G, Meeker HC, Ye X, Flory MJ, et al. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. J Leukoc Biol 2007; 81:1374-85; PMID:17379700; http://dx.doi.org/10. 1189/jlb.1106665.
22. Plummer TH Jr, Elder JH, Alexander S, Phelan AW, Tarentino AL. Demonstration of peptide: N-glycosidase F activity in endo-beta-N- acetylglucosaminidase F preparations. J Biol Chem 1984; 259:10700-4; PMID:6206060.
23. Maley F, Trimble RB, Tarentino AL, Plummer TH Jr. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem 1989; 180:195-204; PMID:2510544; http://dx.doi.org/10.1016/0003-2697(89)90115-2.
24. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41:12868-75; PMID:12379130; http://dx.doi.org/10.1021/ bi025958g.
25. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989.
26. Zou WQ, Langeveld J, Xiao X, Chen S, McGeer PL, Yuan J, et al. PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem 2010; 285:13874-84; PMID:20194495; http://dx.doi.org/10.1074/jbc. M109.088831.
27. Kascsak R. Reiterating the epitope specificity of prion-specific mAb 3F4. J Biol Chem 2010; 285:5; PMID:20452989; http://dx.doi.org/10.1074/jbc.L109. 088831.
28. Bolton DC, Seligman SJ, Bablanian G, Windsor D, Scala LJ, Kim KS, et al. Molecular location of a species-specific epitope on the hamster scrapie agent protein. J Virol 1991; 65:3667-75; PMID:1710287.
29. Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992; 66:2096-101; PMID:1347795.
30. Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859-68; PMID:7966576.
31. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 2001; 10:854-63; PMID:11274476; http://dx.doi.org/10.1110/ps.39201.
32. Gong B, Ramos A, Vázquez-Fernández E, Silva CJ, Alonso J, Liu Z, et al. Probing structural differences between PrP(C) and PrP(Sc) by surface nitration and acetylation: evidence of conformational change in the C-terminus. Biochemistry 2011; 50:4963-72; PMID:21526750; http://dx.doi.org/10. 1021/bi102073j.
33. Neises B, Steglich W. Simple Method for the Esterification of Carboxylic Acids. Angew Chem Int Ed Engl 1978; 17:522-4; http://dx.doi.org/10.1002/anie. 197805221.
34. Che FY, Fricker LD. Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J Mass Spectrom 2005; 40:238-49; PMID:15706629; http://dx.doi.org/10.1002/jms.743.
35. Flinta C, Persson B, Jörnvall H, von Heijne G. Sequence determinants of cytosolic N-terminal protein processing. Eur J Biochem 1986; 154:193-6; PMID:3080313; http://dx.doi.org/10.1111/j.1432-033.1986.tb09378.x.
36. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4:645-50; PMID:17643109; http://dx.doi.org/10.1038/nmeth1066.
37. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press 1989.
38. Kimberlin RH, Walker C. Characteristics of a short incubation model of scrapie in the golden hamster. J Gen Virol 1977; 34:295-304; PMID:402439; http://dx.doi.org/10.1099/0022-1317-34-2-295.
39. Marsh RF, Kimberlin RH. Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology and pathogenesis. J Infect Dis 1975; 131:104-10; PMID:1167884; http://dx.doi.org/10.1093/infdis/131. 2.104.
40. Bessen RA, Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992; 73:329-34; PMID:1531675; http://dx.doi.org/10.1099/0022-1317-73-2-329.
41. Zlotnik I, Rennie JC. Further observations on the experimental transmission of scrapie from sheep and goats to laboratory mice. J Comp Pathol 1963; 73:150-62; PMID:14003830.
42. Prusiner SB, Groth D, Serban A, Stahl N, Gabizon R. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sci USA 1993; 90:2793-7; PMID:8464892; http://dx.doi.org/10.1073/pnas.90.7.2793.